Heteroresistance to fluconazole and voriconazole in Cryptococcus neoformans

被引:98
作者
Mondon, P
Petter, R
Amalfitano, G
Luzzati, R
Concia, E
Polacheck, I
Kwon-Chung, KJ
机构
[1] NIAID, Clin Invest Lab, MMS, NIH, Bethesda, MD 20892 USA
[2] Univ Hosp Verona, Verona, Italy
[3] Hadassah Med Ctr, IL-91120 Jerusalem, Israel
关键词
D O I
10.1128/AAC.43.8.1856
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Cryptococcus neoformans isolates that exhibited unusual patterns of resistance to fluconazole and voriconazole were isolated from seven isolates from two different geographical regions: one isolate from an Israeli non-AIDS patient and six serial isolates fi om an Italian AIDS patient who had suffered six recurrent episodes of cryptococcal meningitis. Each isolate produced cultures with heterogeneous compositions in which most of the cells were susceptible, but cells highly resistant to fluconazole (MICs, greater than or equal to 64 mu g/ml) were recovered at a variable frequency (7 x 10(-3) to 4.6 x 10(-2)), Evidence showed that this type of resistance is innate and is unrelated to drug exposure since the Israeli patient had never been treated with azoles or any other antimycotic agents. Analysis of clonal subpopulations of these two strains showed that they exhibited heterogeneous patterns of resistance. The number of subpopulations which grew on fluconazole or voriconazole agar declined progressively with increasing azole concentration without a sharp cutoff point, For the Italian serial isolates, the number of clonal populations resistant to fluconazole (64 mu g/ml) and voriconazole (1 mu g/ml) increased steadily, yielding the highest number for the isolate from the last episode. Attempts to purify a sensitive subpopulation failed, but clones highly resistant to fluconazole (100 mu g/ml) and moderately resistant to voriconazole (1 mu g/ml) always produced a homogeneous population of resistant cells. Upon maintenance on drug-free medium, however, the majority of the homogeneously resistant cells of these subclones lost their resistance and returned to the stable initial heteroresistant phenotype. The pattern of heteroresistance was not affected by the pH or osmolarity of the medium but was influenced by temperature. The resistance appeared to be suppressed at 35 degrees C and was completely abolished at 40 degrees C. Although heterogeneity in azole resistance among subpopulations of single isolates has been reported for Candida species, the transient changes in expression of resistance under different growth conditions reported here have not been observed in fungal pathogens.
引用
收藏
页码:1856 / 1861
页数:6
相关论文
共 34 条
[1]   Possible development of resistance to fluconazole during suppressive therapy for AIDS-associated cryptococcal meningitis [J].
Armengou, A ;
Porcar, C ;
Mascaro, J ;
GarciaBragado, F .
CLINICAL INFECTIOUS DISEASES, 1996, 23 (06) :1337-1338
[2]   The hidden danger of primary fluconazole prophylaxis for patients with AIDS [J].
Berg, J ;
Clancy, CJ ;
Nguyen, MH .
CLINICAL INFECTIOUS DISEASES, 1998, 26 (01) :186-187
[3]   AZOLE DRUG-RESISTANCE AS A CAUSE OF CLINICAL RELAPSE IN AIDS PATIENTS WITH CRYPTOCOCCAL MENINGITIS [J].
BIRLEY, HDL ;
JOHNSON, EM ;
MCDONALD, P ;
PARRY, C ;
CAREY, PB ;
WARNOCK, DW .
INTERNATIONAL JOURNAL OF STD & AIDS, 1995, 6 (05) :353-355
[4]   Molecular subtypes and antifungal susceptibilities of serial Cryptococcus neoformans isolates in human immunodeficiency virus - Associated cryptococcosis [J].
Brandt, ME ;
Pfaller, MA ;
Hajjeh, RA ;
Graviss, EA ;
Rees, J ;
Spitzer, ED ;
Pinner, RW ;
Mayer, LW ;
Stephens, D ;
Farley, M ;
Rimland, D ;
Baughman, W ;
Lao, C ;
Otte, J ;
Harvey, C ;
Hamill, R ;
Reingold, AL ;
Rothrock, G ;
Pattni, B ;
Daily, P .
JOURNAL OF INFECTIOUS DISEASES, 1996, 174 (04) :812-820
[5]   Reversible fluconazole resistance in Candida albicans: A potential in vitro model [J].
Calvet, HM ;
Yeaman, MR ;
Filler, SG .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (03) :535-539
[6]   SUSCEPTIBILITIES OF SERIAL CRYPTOCOCCUS-NEOFORMANS ISOLATES FROM PATIENTS WITH RECURRENT CRYPTOCOCCAL MENINGITIS TO AMPHOTERICIN-B AND FLUCONAZOLE [J].
CASADEVALL, A ;
SPITZER, ED ;
WEBB, D ;
RINALDI, MG .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (06) :1383-1386
[7]   Methicillin resistance in staphylococci: Molecular and biochemical basis and clinical implications [J].
Chambers, HF .
CLINICAL MICROBIOLOGY REVIEWS, 1997, 10 (04) :781-+
[8]  
De Lencastre H., 1993, European Journal of Clinical Microbiology and Infectious Diseases, V12, pS13
[9]   Impact of sar and agr on methicillin resistance in Staphylococcus aureus [J].
Duran, SP ;
Kayser, FH ;
BergerBachi, B .
FEMS MICROBIOLOGY LETTERS, 1996, 141 (2-3) :255-260
[10]   Increase of methicillin resistance in Staphylococcus aureus caused by deletion of a gene whose product is homologous to lytic enzymes [J].
Fujimura, T ;
Murakami, K .
JOURNAL OF BACTERIOLOGY, 1997, 179 (20) :6294-6301